Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Diabetes & Metabolism|January 3, 2012
Is continuous glucose monitoring (CGM) for everyone? To whom should CGM be prescribed and how?J-P RivelineDiabetes & Metabolism|March 22, 2007
How should postprandial glycemia be treated?G Charpentier, D Dardari, J P RivelineDiabetes & Metabolism|August 3, 2000
Management of drugs affecting blood glucose in diabetic patients with renal failureG Charpentier, J P Riveline, M Varroud-VialArchives Des Maladies Du Coeur Et Des Vaisseaux|January 26, 2005
[Optimising the equilibrium of diabetes and atheromatous progression: myth or reality?]G Charpentier, J P Riveline, M L VirallyDiabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 22, 2024
Perspective of Continuous Glucose Monitoring-Based Interventions at the Various Stages of Type 2 DiabetesR A Ajjan, S Seidu, J P RivelineDiabetes & Metabolism|November 9, 2007
Real-time continuous glucose monitoring using GuardianRT: from research to clinical practiceN Tubiana-Rufi, J-P Riveline, D DardariDiabetes & Metabolism|December 3, 2014
Incretin-based therapy and pancreatic beta cellsS Chon, J-P Riveline, B Blondeau, et al.Diabetes & Metabolism|August 12, 2003
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applicationsJ P Riveline, N Danchin, F Ledru, et al.Diabetes & Metabolism|March 11, 2015
Metabolic roles of PGC-1α and its implications for type 2 diabetesA Besseiche, J-P Riveline, J-F Gautier, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|April 12, 2001
[Silent ischemic cardiopathy: which diabetics to examine?]G Charpentier, J P Riveline, H Lardoux, et al.Pageof 3